Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vinyl Ether SCHEMBL3045123 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| 1,6-Hexanediol SCHEMBL274256 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| Vinyl Ether SCHEMBL1538334 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| Vinyl Ether SCHEMBL247401 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| 1,5-Pentanediol SCHEMBL1627938 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| Vinyl Ether SCHEMBL599269 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| Vinyl Ether SCHEMBL3102911 | 1.00 | LMNA (0.38) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| 1,4-Butanediol SCHEMBL64717 | 0.97 | SMN1; SMN2 (0.35) | LMNATSHRALDH1A1HSD17B10MEN1 | |
| Vinyl Ether SCHEMBL475916 | 0.90 | TSHR (0.33) | TSHRALDH1A1 | |
| Tridecan-1-Ol SCHEMBL22129256 | 0.87 | TSHR (0.62) | LMNATSHRALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220033334-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| US-20220033335-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| EP-3889125-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | Maruzen Petrochemical Co., Ltd. (JP) | 2021-10-06 | — | — | EP | disclosed |
| EP-3889126-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | Maruzen Petrochemical Co., Ltd. (JP) | 2021-10-06 | — | — | EP | disclosed |
| CN-113166016-A | Method for producing divinyl ether compound having alkylene skeleton | 丸善石油化学株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-113166015-A | Method for producing divinyl ether compound having alkylene skeleton | 丸善石油化学株式会社 | 2021-07-23 | — | — | CN | disclosed |
| US-8728662-B2 | Process for producing polyradical compound and battery cell | NEC CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| CN-101466747-B | Process for production of polyradical compound and battery cell | NIPPON ELECTRIC CO | 2011-09-28 | — | — | CN | disclosed |
| US-20100255372-A1 | PROCESS FOR PRODUCING POLYRADICAL COMPOUND AND BATTERY CELL | NEC CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| CN-101466747-A | Process for production of polyradical compound and battery cell | NIPPON ELECTRIC CO (JP) | 2009-06-24 | — | — | CN | disclosed |
| EP-2025689-A1 | PROCESS FOR PRODUCTION OF POLYRADICAL COMPOUND AND BATTERY CELL | NEC Corporation (JP) | 2009-02-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033334-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | DECR2, KAT8, DECR1 | LMNA 215/4885TSHR 3684/4885ALDH1A1 2263/4885 |
| US-20220033335-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | DECR2, DECR1, ACMSD | LMNA 657/4885TSHR 3362/4885ALDH1A1 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.